Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

Breast malignant, males, children

In situ carcinoma

Comedo DCIS / comedocarcinoma


Reviewer: Dina Kandil, M.D. (see Reviewers page)
Revised: 10 January 2012, last major update January 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.

Definition
=========================================================================

● High grade DCIS with central expansile comedonecrosis (central necrosis within involved ducts)
● Necrosis is due to apoptosis and oncosis (passive cell death, Ultrastruct Pathol 2000;24:135)

Epidemiology
=========================================================================

● Has similar hormonal and reproductive risk factors as invasive ductal carcinoma, unlike non-comedo DCIS (Cancer Epidemiol Biomarkers Prev 2009;18:1507)

Clinical
=========================================================================

● 1/3 appear multicentric, but many are actually continuous in 3 dimensions, as demonstrated by serial section mapping studies
● 10% are bilateral
● 1-3% of patients have axillary nodal metastases, even without evidence of invasive carcinoma
● Lesions may be extensive (>5 cm); must examine carefully for invasive carcinoma

X-ray
=========================================================================

● Mammography usually shows linear and branching microcalcifications due to calcification of necrotic material, more often central than other tumors
● Occasionally lacks calcifications

X-ray images
=========================================================================


Linear and branching microcalcifications

Gross description
=========================================================================

● Cheesy appearance (resembling comedones) due to plugging of thick walled ducts with necrotic material

Micro description
=========================================================================

● Solid growth of large, pleomorphic, high grade cells with central expansile necrosis
● Frequent mitotic figures
● Myoepithelial cell layer may be attenuated
● Coarse microcalcifications are common
● Periductal fibrosis and inflammation are common
● Often cancerization of lobules
● May have branching and budding

Micro images
=========================================================================



Central necrosis with dystrophic calcifications (AFIP)

       
Classic features


Periductal fibrosis


Involving lobules


Cancerization of lobules

   
HER2+


Androgen receptor+

Other images: central necrosis #1, #2

Cytology images
=========================================================================


Other images: low power; atypical cells with large nuclei #1; #2; #3

Virtual slides
=========================================================================



DCIS and LCIS


Calponin

Positive stains
=========================================================================

● HER2 amplification (Cancer 2000;89:2153), p53 (Lab Invest 1994;71:67)
● Also P-cadherin (Virchows Arch 2007;450:73)

Negative stains
=========================================================================

● ER, PR (Br J Surg 2005;92:429)

Molecular/cytogenetics description
=========================================================================

● Aneuploid
● Multicentric tumors were monoclonal in one study (Hum Pathol 2003;34:1163)

Molecular/cytogenetics images
=========================================================================



Tetraploid DNA


Aneuploid DNA

Differential diagnosis
=========================================================================

● Invasive ductal carcinoma with central necrosis (J Med Case Reports 2007;1:83)
● Intraductal papilloma with comedo-like necrosis (Ann Diagn Pathol 2004;8:276)

Additional references
=========================================================================

Arch Pathol Lab Med 1996;120:81

End of Breast malignant, males, children > In situ carcinoma > Comedo DCIS / comedocarcinoma


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).